Philip Michael Reaper

This inventor holds 20 USPTO granted patents and 13 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Cancer Treatment. Top assignees: Vertex Pharmaceuticals, Inc., The University of Newcastle Upon Tyne. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Michael Reaper. Retrieved from https://idiyas.com/inventor/philip-michael-reaper

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 13)

% Patents Active = 65.0

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 5.8

ph-index = 12

Forward Citations = 338(Granted Patents)

Location History:

Shillingford, GB (2013 - 2017)
Richmond, GB (2014 - 2021)
Abingdon, GB (2014 - 2022)

Company Filing History:

20 out of 1,169

Vertex Pharmaceuticals, Inc.

patents

1 out of 62

The University of Newcastle Upon Tyne

patents

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

Areas of Expertise:

ATR Inhibitors

Cancer Treatment

DNA Damage Agents

Combination Therapies

Substituted Pyrazines

Pyrazin-2-Amine

Inhibitors

Aminopyrazines

Kinase Inhibitors

Compounds

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11464774 - Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors (2022-10-11),

2. 11110086 - Compounds useful as inhibitors of ATR kinase and combination therapies thereof (2021-09-07),

3. 10961232 - Substituted pyrazines as ATR kinase inhibitors (2021-03-30),

4. 10813929 - Treating cancer with ATR inhibitors (2020-10-27),

5. 10479784 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2019-11-19),

6. 10478430 - Compounds useful as inhibitors of ATR kinase and combination therapies thereof (2019-11-19),

7. 9791456 - Method for measuring ATR inhibition mediated increases in DNA damage (2017-10-17),

8. 9701674 - Substituted pyrazines as ATR kinase inhibitors (2017-07-11),

9. 9630956 - Compounds useful as inhibitors of ATR kinase (2017-04-25),

10. 9365557 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2016-06-14),

11. 9334244 - Compounds useful as inhibitors of ATR kinase (2016-05-10),

12. 9096584 - Compounds useful as inhibitors of ATR kinase (2015-08-04),

13. 9062008 - Compounds useful as inhibitors of ATR kinase (2015-06-23),

14. 8999632 - Method for measuring ATR inhibition mediated increases in DNA damage (2015-04-07),

15. 8969356 - Compounds useful as inhibitors of ATR kinase (2015-03-03),

Title: Inventor Philip Michael Reaper

Introduction: Philip Michael Reaper is a renowned inventor based in Richmond, Great Britain. He is known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Philip Michael Reaper's most recent patents include a revolutionary solar-powered water purification system and a cutting-edge biodegradable packaging material, both of which have garnered significant attention in the industry.

Career Highlights: Throughout his illustrious career, Philip Michael Reaper has accumulated a remarkable portfolio of patents spanning sustainable technologies, healthcare devices, and consumer products. His commitment to addressing global challenges through inventive solutions has earned him widespread acclaim.

Collaborations: Philip Michael Reaper has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in advancing the development and commercialization of his patented technologies.

Conclusion: In conclusion, Philip Michael Reaper stands as a visionary inventor who continues to push the boundaries of innovation. His passion for creating impactful solutions underscores his status as a trailblazer in the world of inventions.

Profile summary based on public USPTO records.